194 related articles for article (PubMed ID: 30064446)
21. LincRNA-p21 knockdown reversed tumor-associated macrophages function by promoting MDM2 to antagonize* p53 activation and alleviate breast cancer development.
Zhou L; Tian Y; Guo F; Yu B; Li J; Xu H; Su Z
Cancer Immunol Immunother; 2020 May; 69(5):835-846. PubMed ID: 32062693
[TBL] [Abstract][Full Text] [Related]
22. Mdm2-P53 Interaction Inhibitor with Cisplatin Enhances Apoptosis in Colon and Prostate Cancer Cells In-Vitro.
Gupta A; Behl T; Heer HR; Deshmukh R; Sharma PL
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3341-3351. PubMed ID: 31759358
[TBL] [Abstract][Full Text] [Related]
23. Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatment.
To KKW; Cheung KM; Cho WCS
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7217-7234. PubMed ID: 36905422
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of microarray data to determine gene indicators involved in cisplatin resistance in non-small cell lung cancer.
Sheikhshabani SH; Modarres P; Ghafouri-Fard S; Amini-Farsani Z; Khodaee L; Shaygan N; Amini-Farsani Z; Omrani MD
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1970. PubMed ID: 38351531
[TBL] [Abstract][Full Text] [Related]
25. The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein.
Muscolini M; Montagni E; Palermo V; Di Agostino S; Gu W; Abdelmoula-Souissi S; Mazzoni C; Blandino G; Tuosto L
J Biol Chem; 2011 Nov; 286(46):39693-702. PubMed ID: 21953469
[TBL] [Abstract][Full Text] [Related]
26. Early-Stage Metastasis Requires Mdm2 and Not p53 Gain of Function.
Hauck PM; Wolf ER; Olivos DJ; Batuello CN; McElyea KC; McAtarsney CP; Cournoyer RM; Sandusky GE; Mayo LD
Mol Cancer Res; 2017 Nov; 15(11):1598-1607. PubMed ID: 28784612
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen potentiates non-small cell lung cancer progression via PKA-PGC-1ɑ axis.
Lei J; Wu L; Zhang N; Liu X; Zhang J; Kuang L; Chen J; Chen Y; Li D; Li Y
Mol Biomed; 2024 May; 5(1):19. PubMed ID: 38782774
[TBL] [Abstract][Full Text] [Related]
28. TNFAIP8 regulates autophagy, cell steatosis, and promotes hepatocellular carcinoma cell proliferation.
Niture S; Gyamfi MA; Lin M; Chimeh U; Dong X; Zheng W; Moore J; Kumar D
Cell Death Dis; 2020 Mar; 11(3):178. PubMed ID: 32152268
[TBL] [Abstract][Full Text] [Related]
29. Evodiamine potentiates cisplatin-induced cell death and overcomes cisplatin resistance in non-small-cell lung cancer by targeting SOX9-β-catenin axis.
Panda M; Biswal S; Biswal BK
Mol Biol Rep; 2024 Apr; 51(1):523. PubMed ID: 38630183
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin chromatin remodelling after DNA damage is associated with the expression of key cancer genes and pathways.
Cole AJ; Dickson KA; Liddle C; Stirzaker C; Shah JS; Clifton-Bligh R; Marsh DJ
Cell Mol Life Sci; 2021 Feb; 78(3):1011-1027. PubMed ID: 32458023
[TBL] [Abstract][Full Text] [Related]
31. Identification of arnicolide C as a novel chemosensitizer to suppress mTOR/E2F1/FANCD2 axis in non-small cell lung cancer.
Chen YF; Pang YC; Wang HC; Wu PE; Chen ZJ; Huang D; Peng DL; Yan YM; Liu C; Wu LC; Fan XZ; Cheng YX; Liu YQ
Br J Pharmacol; 2024 Apr; 181(8):1221-1237. PubMed ID: 37926864
[TBL] [Abstract][Full Text] [Related]
32. NFAT activation by FKBP52 promotes cancer cell proliferation by suppressing p53.
Hanaki S; Habara M; Tomiyasu H; Sato Y; Miki Y; Masaki T; Shibutani S; Shimada M
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38803221
[TBL] [Abstract][Full Text] [Related]
33. BAI1 Suppresses Medulloblastoma Formation by Protecting p53 from Mdm2-Mediated Degradation.
Zhu D; Osuka S; Zhang Z; Reichert ZR; Yang L; Kanemura Y; Jiang Y; You S; Zhang H; Devi NS; Bhattacharya D; Takano S; Gillespie GY; Macdonald T; Tan C; Nishikawa R; Nelson WG; Olson JJ; Van Meir EG
Cancer Cell; 2018 Jun; 33(6):1004-1016.e5. PubMed ID: 29894688
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin-resistance induces lung squamous carcinoma cell growth by nicotine-mediated α7nAchR/HDAC1/Cyclin D1/pRb cell cycle activation.
Rao L; Guo D; Wu JP
Cell Biochem Funct; 2024 Mar; 42(2):e3990. PubMed ID: 38504444
[TBL] [Abstract][Full Text] [Related]
35. [High expression of COX6B2 in gastric cancer is associated with poor long-term prognosis and promotes cell proliferation and cell cycle progression by inhibiting p53 signaling].
Shen M; Zhao N; Deng X; Deng M
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):289-297. PubMed ID: 38501414
[TBL] [Abstract][Full Text] [Related]
36. Lipopolysaccharide Affects the Proliferation and Glucose Metabolism of Cervical Cancer Cells Through the FRA1/MDM2/p53 Pathway.
Jiang X; Yuan J; Dou Y; Zeng D; Xiao S
Int J Med Sci; 2021; 18(4):1030-1038. PubMed ID: 33456361
[TBL] [Abstract][Full Text] [Related]
37. Selective activation of p53-mediated tumour suppression in high-grade tumours.
Junttila MR; Karnezis AN; Garcia D; Madriles F; Kortlever RM; Rostker F; Brown Swigart L; Pham DM; Seo Y; Evan GI; Martins CP
Nature; 2010 Nov; 468(7323):567-71. PubMed ID: 21107427
[TBL] [Abstract][Full Text] [Related]
38. Novel evidence for retinoic acid-induced G (Rig-G) as a tumor suppressor by activating p53 signaling pathway in lung cancer.
Sun J; Wang X; Liu W; Ji P; Shang A; Wu J; Zhou H; Quan W; Yao Y; Yang Y; Gu C; Sun Z; Goel A; Weng W; Li D
FASEB J; 2020 Sep; 34(9):11900-11912. PubMed ID: 32741018
[TBL] [Abstract][Full Text] [Related]
39. Recombined humanized endostatin-induced suppression of HMGB1 expression inhibits proliferation of NSCLC cancer cells.
Meng FJ; Wang S; Yan YJ; Wang CY; Guan ZY; Zhang J
Thorac Cancer; 2019 Jan; 10(1):90-95. PubMed ID: 30485686
[TBL] [Abstract][Full Text] [Related]
40. Antiproliferative and apoptotic activities of ketonucleosides and keto-C-glycosides against non-small-cell lung cancer cells with intrinsic drug resistance.
Paterson J; Uriel C; Egron MJ; Herscovici J; Antonakis K; Alaoui-Jamali MA
Antimicrob Agents Chemother; 1998 Apr; 42(4):779-84. PubMed ID: 9559782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
